PLx Pharma Inc. – NASDAQ:PLXP

Financial Health
0
1
2
3
4
5
6
7
8
9

PLx Pharma stock price monthly change

-86.36%
month

PLx Pharma stock price quarterly change

-96.67%
quarter

PLx Pharma stock price yearly change

-99.77%
year

PLx Pharma key metrics

Market Cap
2.53M
Enterprise value
N/A
P/E
-0.17
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
0.75
Price/Book
0.13
PEG ratio
-0.11
EPS
-0.54
Revenue
4.54M
EBITDA
-52.07M
Income
-15.14M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-606.92%
Oper. margin
-1417.83%
Gross margin
4.46%
EBIT margin
-1417.83%
EBITDA margin
-1146.03%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

PLx Pharma stock price history

PLx Pharma stock forecast

PLx Pharma financial statements

PLx Pharma Inc. (NASDAQ:PLXP): Profit margin
Dec 2021 1.59M 3.56M 223.78%
Mar 2022 2.08M -3.37M -161.98%
Jun 2022 483K -9.17M -1900.21%
Sep 2022 386K -6.15M -1594.56%
PLx Pharma Inc. (NASDAQ:PLXP): Debt to assets
Dec 2021 76642000 24.96M 32.57%
Mar 2022 60858000 18.87M 31.01%
Jun 2022 44540000 12.03M 27.02%
Sep 2022 33224000 7.02M 21.14%
PLx Pharma Inc. (NASDAQ:PLXP): Cash Flow
Dec 2021 -13.36M 458 198.23K
Mar 2022 -16.89M 0 0
Jun 2022 -18.09M 0 1.33M
Sep 2022 -10.98M 0 1.08M

PLx Pharma alternative data

PLx Pharma Inc. (NASDAQ:PLXP): Employee count
Aug 2023 16
Sep 2023 16
Oct 2023 16
Nov 2023 16
Dec 2023 16
Jan 2024 16
Feb 2024 16
Mar 2024 16
Apr 2024 16
May 2024 16
Jun 2024 16
Jul 2024 16

PLx Pharma other data

PLx Pharma Inc. (NASDAQ:PLXP): Insider trades (number of shares)
Period Buy Sel
Jun 2021 8000 0
Mar 2022 17800 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
GIORDANO NATASHA director, officer.. Common Stock 4,100 $3.65 $14,977
Purchase
O'CONNOR RITA M officer: Chief Financial Officer
Common Stock 3,700 $3.66 $13,524
Purchase
O'CONNOR RITA M officer: Chief Financial Officer
Common Stock 10,000 $3.66 $36,600
Purchase
VALENTINO MICHAEL J director, officer.. Common Stock 8,000 $12.48 $99,808
Purchase
VALENTINO MICHAEL J director, officer.. Common Stock 25,000 N/A N/A
Purchase
HADDEN JOHN director
Common Stock 1,000 N/A N/A
Purchase
HADDEN JOHN director
Common Stock 1,000 $5.46 $5,455
Purchase
HADDEN JOHN director
Common Stock 500 N/A N/A
Purchase
VALENTINO MICHAEL J director, officer.. Warrants (right to buy) 291,390 N/A N/A
Purchase
VALENTINO MICHAEL J director, officer.. Common Stock 264,900 N/A N/A
Insider Compensation
Ms. Natasha Giordano (1960) Chief Executive Officer, Pres & Director $912,330
Ms. Rita M. O'Connor CPA, CPA (1968) Chief Financial Officer and Head of Manufacturing & Supply Chain
$638,120
Mr. Michael J. Valentino (1954) Executive Chairman $406,250
Wednesday, 12 April 2023
InvestorPlace
Tuesday, 11 April 2023
InvestorPlace
PennyStocks
Friday, 11 November 2022
Seeking Alpha
Thursday, 10 November 2022
Zacks Investment Research
Wednesday, 26 October 2022
GlobeNewsWire
Friday, 12 August 2022
Seeking Alpha
Zacks Investment Research
Friday, 13 May 2022
Seeking Alpha
Zacks Investment Research
Friday, 22 April 2022
GlobeNewsWire
Friday, 11 March 2022
Seeking Alpha
Zacks Investment Research
Tuesday, 1 March 2022
GlobeNewsWire
Tuesday, 22 February 2022
GlobeNewsWire
Wednesday, 15 December 2021
Zacks Investment Research
Monday, 22 November 2021
GlobeNewsWire
Friday, 12 November 2021
Seeking Alpha
Monday, 1 November 2021
GlobeNewsWire
Thursday, 14 October 2021
Market Watch
Friday, 17 September 2021
Seeking Alpha
Thursday, 9 September 2021
GlobeNewsWire
Thursday, 26 August 2021
GlobeNewsWire
  • When is PLx Pharma's next earnings date?

    Unfortunately, PLx Pharma's (PLXP) next earnings date is currently unknown.

  • Does PLx Pharma pay dividends?

    No, PLx Pharma does not pay dividends.

  • How much money does PLx Pharma make?

    PLx Pharma has a market capitalization of 2.53M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 26873.38% to 8.21M US dollars.

  • What is PLx Pharma's stock symbol?

    PLx Pharma Inc. is traded on the NASDAQ under the ticker symbol "PLXP".

  • What is PLx Pharma's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of PLx Pharma?

    Shares of PLx Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are PLx Pharma's key executives?

    PLx Pharma's management team includes the following people:

    • Ms. Natasha Giordano Chief Executive Officer, Pres & Director(age: 65, pay: $912,330)
    • Ms. Rita M. O'Connor CPA, CPA Chief Financial Officer and Head of Manufacturing & Supply Chain(age: 57, pay: $638,120)
    • Mr. Michael J. Valentino Executive Chairman(age: 71, pay: $406,250)
  • How many employees does PLx Pharma have?

    As Jul 2024, PLx Pharma employs 16 workers.

  • When PLx Pharma went public?

    PLx Pharma Inc. is publicly traded company for more then 11 years since IPO on 13 Mar 2014.

  • What is PLx Pharma's official website?

    The official website for PLx Pharma is plxpharma.com.

  • Where are PLx Pharma's headquarters?

    PLx Pharma is headquartered at 9 Fishers Lane, Sparta, NJ.

  • How can i contact PLx Pharma?

    PLx Pharma's mailing address is 9 Fishers Lane, Sparta, NJ and company can be reached via phone at +973 4096541.

PLx Pharma company profile:

PLx Pharma Inc.

plxpharma.com
Exchange:

NASDAQ

Full time employees:

16

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

9 Fishers Lane
Sparta, NJ 07871

CIK: 0001497504
ISIN: US72942A1079
CUSIP: 72942A107